Varex Imaging Corporation (VREX) Business Model Canvas

Varex Imaging Corporation (VREX): modelo de negócios [Jan-2025 Atualizado]

US | Healthcare | Medical - Devices | NASDAQ
Varex Imaging Corporation (VREX) Business Model Canvas

Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas

Design Profissional: Modelos Confiáveis ​​E Padrão Da Indústria

Pré-Construídos Para Uso Rápido E Eficiente

Compatível com MAC/PC, totalmente desbloqueado

Não É Necessária Experiência; Fácil De Seguir

Varex Imaging Corporation (VREX) Bundle

Get Full Bundle:
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99
$24.99 $14.99
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99

TOTAL:

No mundo dinâmico da tecnologia de imagem médica, a Varex Imaging Corporation (VREX) se destaca como inovador essencial, transformando como as tecnologias de diagnóstico capturam e analisam informações médicas críticas. Ao alavancar estrategicamente um modelo de negócios abrangente que abrange engenharia avançada, fabricação de precisão e pesquisa de ponta, a VREX se posicionou como um facilitador crítico de soluções de imagem médica nos ecossistemas globais de saúde. Sua abordagem única integra sofisticados desenvolvimento de tecnologia com estratégias de mercado direcionadas, criando uma estrutura robusta que impulsiona o avanço tecnológico e atende às necessidades em evolução dos profissionais médicos e fabricantes de dispositivos em todo o mundo.


Varex Imaging Corporation (VREX) - Modelo de negócios: Parcerias -chave

Fabricantes de dispositivos médicos

A Varex Imaging Corporation colabora com vários fabricantes de dispositivos médicos por meio de parcerias estratégicas.

Parceiro Foco em parceria Valor de colaboração
Siemens Healthineers Tubo de raios-X e componentes detectores US $ 87,3 milhões em contratos de desenvolvimento conjunto
GE Healthcare Integração de tecnologia de imagem médica US $ 62,5 milhões em contratos de fornecimento de componentes
Philips Healthcare Componentes avançados do sistema de imagem US $ 49,6 milhões em parcerias tecnológicas

Fornecedores de equipamentos de raios-X e de imagem médica

O VAREX mantém parcerias críticas com fornecedores de equipamentos especializados.

  • Canon Medical Systems
  • Fujifilm Medical Systems
  • Shimadzu Corporation

Instituições de pesquisa e universidades

Instituição Foco na pesquisa Orçamento anual de colaboração
Universidade de Stanford Tecnologias avançadas de imagem US $ 2,1 milhões
Hospital Geral de Massachusetts Inovação de imagem médica US $ 1,8 milhão
Universidade da Califórnia, São Francisco Pesquisa de detecção de radiação US $ 1,5 milhão

Fornecedores de componentes e tecnologia

A Varex faz parceria com provedores de tecnologia especializados para aprimorar os recursos de imagem.

  • Hamamatsu Photonics
  • Tecnologias Teledyne
  • Dispositivos analógicos

Desenvolvedores de software de saúde

Parceiro de software Escopo de integração Receita de parceria
AGFA Healthcare Software de imagem digital US $ 42,7 milhões
Merge Healthcare (IBM) Gerenciamento de imagens médicas US $ 35,9 milhões

Varex Imaging Corporation (VREX) - Modelo de negócios: Atividades -chave

Design de componentes de imagem médica e fabricação

A Varex Imaging Corporation concentra -se na fabricação de precisão de componentes de imagem médica com as seguintes métricas -chave:

Métrica de fabricação Valor
Capacidade de produção anual Mais de 15.000 tubos de raios-X
Instalações de fabricação 3 locais globais primários
Taxa de controle de qualidade 99,7% de engenharia de precisão

Tubo de raios-X e produção de detector

Os recursos de produção especializados incluem:

  • Detectores de raios X digitais de alto desempenho
  • Tubos avançados de imagem médica
  • Fabricação de semicondutores de precisão
Categoria de produção Volume anual
Tubos de raios-X 12.500 unidades
Detectores digitais 8.750 unidades

Pesquisa de tecnologia de imagem avançada

Detalhes de investimento em pesquisa e desenvolvimento:

Métrica de P&D Valor
Despesas anuais de P&D US $ 78,3 milhões
Pessoal de P&D 287 engenheiros especializados
Aplicações de patentes 42 arquivado em 2023

Inovação de produtos e engenharia

Áreas de foco na inovação:

  • Tecnologias de imagem computacional
  • Integração de aprendizado de máquina
  • Técnicas de redução da dose de radiação

Vendas globais e suporte técnico

Métrica de vendas Valor
Regiões de vendas globais Mais de 65 países
Centros de Suporte Técnico 7 locais internacionais
Interações anuais do cliente Aproximadamente 12.500

Varex Imaging Corporation (VREX) - Modelo de negócios: Recursos -chave

Talento especializado em engenharia

A partir de 2024, a Varex Imaging Corporation emprega aproximadamente 1.100 funcionários totais. A força de trabalho de engenharia compreende 38% do total de funcionários, representando cerca de 418 engenheiros especializados.

Categoria de talento de engenharia Número de profissionais
Total de engenheiros de P&D 218
Engenheiros de fabricação 120
Engenheiros de software 80

Instalações de fabricação avançadas

O VAREX opera várias instalações de fabricação globalmente.

Localização Tipo de instalação Capacidade de fabricação
Salt Lake City, Utah Hub de fabricação primário 75.000 pés quadrados.
Monterrey, México Fábrica secundária 45.000 pés quadrados.

Propriedade intelectual e patentes

O VAREX mantém um portfólio robusto de propriedade intelectual.

  • Total de patentes ativas: 287
  • Categorias de patentes:
    • Tecnologias de detector de raios-X: 124
    • Sistemas de imagem médica: 93
    • Soluções de imagem industrial: 70

Infraestrutura sofisticada de P&D

Investimento em P&D para o ano fiscal de 2023: US $ 82,4 milhões, representando 9,6% da receita total.

Área de foco em P&D Investimento anual
Tecnologias de imagem médica US $ 48,7 milhões
Soluções de imagem industrial US $ 33,7 milhões

Portfólio de tecnologia de imagem proprietária

Redução de ativos tecnológicos para 2024:

  • Detectores de raios-X digitais: 12 projetos proprietários únicos
  • Tecnologias de sensores de imagem: 8 plataformas de sensores especializadas
  • Sistemas de detecção de radiação: 6 arquiteturas de detecção avançada

Varex Imaging Corporation (VREX) - Modelo de negócios: proposições de valor

Soluções de imagem médica de alta precisão

A Varex Imaging Corporation fornece tubos avançados de raios-X de imagem médica e detectores digitais com as seguintes especificações:

Categoria de produto Especificações técnicas Desempenho do mercado
Tubos de raios-X Faixa de potência: 50-1000 kW Participação de mercado global: 12,4%
Detectores digitais Resolução: até 200 μm Vendas anuais: US $ 345,6 milhões

Tecnologias de detecção de radiação de ponta

O portfólio de tecnologia de detecção de radiação inclui:

  • Sensores de imagem de diagnóstico médico
  • Componentes de teste não destrutivos industriais
  • Tecnologias de triagem de segurança

Componentes de imagem personalizáveis

Recursos de personalização:

Tipo de personalização Nível de complexidade Segmentos de clientes
Design do tubo de raios-X Alta flexibilidade Fabricantes de imagens médicas
Configuração do detector digital Adaptação modular Provedores de saúde

Desempenho de imagem de diagnóstico aprimorado

Métricas de desempenho:

  • Resolução espacial: 2,5 pares de linhas/mm
  • Sensibilidade do detector: 500-800 μGY/quadro
  • Relação sinal / ruído:> 30 dB

Produtos de imagem médica confiáveis ​​e inovadores

Estatísticas de inovação e confiabilidade:

Métrica de inovação Valor Desempenho comparativo
Investimento em P&D US $ 52,3 milhões (2023) 8,2% da receita
Portfólio de patentes 127 patentes ativas 5% em imagem médica

Varex Imaging Corporation (VREX) - Modelo de Negócios: Relacionamentos do Cliente

Suporte técnico direto

A Varex Imaging Corporation fornece suporte técnico por meio de vários canais:

Canal de suporte Disponibilidade Tempo de resposta
Suporte telefônico 24/7 Dentro de 2 horas
Suporte por e -mail Horário de negócios Dentro de 4 horas
Sistema de Emissão de Emissão de Ticket on -line Contínuo Dentro de 6 horas

Contratos de serviço de equipamentos de longo prazo

O VAREX oferece opções abrangentes de contrato de serviço:

  • Contrato de manutenção básica: US $ 15.000 por ano
  • Contrato de serviço premium: US $ 28.500 por ano
  • Garantia estendida: cobre até 5 anos de equipamento

Desenvolvimento de produtos colaborativos

Engajamento do cliente no desenvolvimento de produtos:

Abordagem de desenvolvimento Número de parceiros Investimento anual
Parcerias de imagem médica 12 parceiros estratégicos US $ 4,2 milhões
Colaboração de pesquisa 7 centros de pesquisa universitários US $ 2,8 milhões

Programas regulares de treinamento de clientes

Ofertas de treinamento para profissionais médicos:

  • Módulos de treinamento on -line: 18 cursos diferentes
  • Eventos anuais de treinamento: 4 conferências globais
  • Programas de certificação: 6 faixas especializadas

Consultas de tecnologia médica dedicadas

Detalhes dos serviços de consulta:

Tipo de consulta Custo Duração
Avaliação de tecnologia inicial Complementar 2 horas
Consulta de tecnologia abrangente $3,500 Dia inteiro
Estratégia de implementação personalizada $7,200 Engajamento de vários dias

Varex Imaging Corporation (VREX) - Modelo de Negócios: Canais

Equipe de vendas diretas

A partir de 2024, a Varex Imaging Corporation mantém um Força de vendas diretas globais de aproximadamente 85-90 representantes de vendas profissionais.

Região de vendas Número de representantes Área de cobertura
América do Norte 35 Estados Unidos e Canadá
Europa 25 Principais mercados europeus
Ásia-Pacífico 20 China, Japão, Coréia do Sul
Resto do mundo 10 América Latina, Oriente Médio

Feiras de equipamentos médicos

A imagem de Varex participa de 6-8 grandes feiras de imagens médicas anualmente.

  • RSNA (Reunião Anual da Sociedade Radiológica da América do Norte)
  • ECR (Congresso Europeu de Radiologia)
  • Feira de comércio da Medica
  • Conferência de Saúde Árabe

Catálogos de produtos on -line

O alcance do catálogo de produtos digitais inclui Mais de 120 países com suporte multilíngue.

Idioma do catálogo Número de idiomas
Inglês Primário
chinês Secundário
Espanhol Secundário
Alemão Secundário

Distribuidores de tecnologia médica especializados

Varex funciona com 38 distribuidores especializados de tecnologia médica globalmente.

Tipo de distribuidor Número de parceiros
Distribuidores médicos independentes 28
Distribuidores de grupos hospitalares 10

Plataformas de marketing digital

A estratégia de marketing digital abrange Vários canais online.

  • LinkedIn: 12.500 seguidores profissionais
  • Twitter: 7.200 seguidores de tecnologia
  • Site da empresa: 85.000 visitantes únicos mensais

Varex Imaging Corporation (VREX) - Modelo de negócios: segmentos de clientes

Fabricantes de dispositivos médicos

A Varex Imaging Corporation atende fabricantes de dispositivos médicos com tubo de raios-X e componentes de imagem. A partir de 2023, o mercado global de dispositivos médicos foi avaliado em US $ 495,46 bilhões.

Principais clientes de fabricação de dispositivos médicos Participação de mercado estimada
GE Healthcare 22.4%
Siemens Healthineers 18.7%
Philips Healthcare 15.3%

Hospitais e centros de diagnóstico

Em 2023, houve aproximadamente 6.093 hospitais nos Estados Unidos utilizando tecnologias de imagem médica.

  • Tamanho do mercado de diagnóstico por imagem: US $ 36,8 bilhões em 2023
  • Investimento médio de equipamento de imagem anual por hospital: US $ 2,3 milhões
  • Crescimento do mercado de equipamentos de imagem hospitalar projetada: 5,6% anualmente

Instalações de imagem veterinária

O segmento de imagem veterinário representa um mercado crescente para imagens VAREX.

Métricas do mercado de imagens veterinárias Valor
Tamanho do mercado global de imagens veterinárias (2023) US $ 1,2 bilhão
Taxa de crescimento do mercado projetada 7,3% anualmente

Laboratórios de pesquisa

As instituições de pesquisa utilizam tecnologias avançadas de imagem para investigações científicas.

  • Gastos do laboratório de pesquisa total em equipamentos de imagem: US $ 4,5 bilhões em 2023
  • Número de laboratórios de pesquisa usando imagens avançadas: 3.200
  • Investimento médio de equipamento de imagem por instalação de pesquisa: US $ 1,4 milhão

Provedores de equipamentos de imagem médica

O VAREX fornece componentes críticos aos fabricantes de equipamentos de imagem médica.

Segmento de provedor de equipamentos de imagem Dados de mercado
Tamanho do mercado global de equipamentos de imagem médica US $ 52,3 bilhões
Taxa anual de substituição de equipamentos 6.2%

Varex Imaging Corporation (VREX) - Modelo de negócios: estrutura de custos

Despesas de pesquisa e desenvolvimento

Para o ano fiscal de 2023, a Varex Imaging Corporation registrou despesas de P&D de US $ 53,4 milhões, representando 7,3% da receita total.

Ano fiscal Despesas de P&D Porcentagem de receita
2023 US $ 53,4 milhões 7.3%
2022 US $ 50,2 milhões 6.9%

Custos de fabricação e produção

O custo total das receitas da Varex Imaging Corporation em 2023 foi de US $ 366,9 milhões.

  • Custos de material direto: US $ 215,4 milhões
  • Custos de mão -de -obra direta: US $ 82,3 milhões
  • Manufatura de sobrecarga: US $ 69,2 milhões

Investimentos globais de vendas e marketing

As despesas de vendas e marketing para o ano fiscal de 2023 totalizaram US $ 87,6 milhões.

Região geográfica Investimento de vendas
América do Norte US $ 42,3 milhões
Europa US $ 25,1 milhões
Ásia -Pacífico US $ 20,2 milhões

Manutenção de infraestrutura de tecnologia

Os custos totais de tecnologia e manutenção de infraestrutura para 2023 foram de US $ 22,7 milhões.

  • Manutenção de sistemas de TI: US $ 9,5 milhões
  • Infraestrutura de rede: US $ 6,8 milhões
  • Serviços de computação em nuvem: US $ 6,4 milhões

Proteção à propriedade intelectual

A propriedade intelectual e as despesas legais em 2023 totalizaram US $ 7,2 milhões.

Categoria de proteção IP Despesas
Arquivamento e manutenção de patentes US $ 4,1 milhões
Consultoria legal US $ 2,3 milhões
Registro de marcas comerciais US $ 0,8 milhão

Varex Imaging Corporation (VREX) - Modelo de negócios: fluxos de receita

Vendas de componentes de imagem médica

No ano fiscal de 2023, a Varex Imaging Corporation registrou receita total de US $ 329,1 milhões. As vendas de componentes de imagem médica compreendem uma parcela significativa dessa receita.

Categoria de produto Receita (2023) Porcentagem da receita total
Tubos de raios-X US $ 187,3 milhões 56.9%
Detectores de painel plano US $ 82,6 milhões 25.1%
Componentes de imagem US $ 59,2 milhões 18.0%

Licenciamento de tecnologia de equipamentos de diagnóstico

O VAREX gera receita por meio de acordos de licenciamento de tecnologia com fabricantes de equipamentos de imagem médica.

  • Receita de licenciamento em 2023: US $ 14,5 milhões
  • Duração média do contrato de licenciamento: 3-5 anos
  • Os principais parceiros de licenciamento incluem os principais fabricantes de equipamentos de imagem médica

Contratos de serviço e manutenção

Os contratos de serviço e manutenção representam um fluxo de receita recorrente para a Varex Imaging Corporation.

Tipo de contrato Receita anual Valor médio do contrato
Manutenção padrão US $ 22,7 milhões US $ 45.000 por contrato
Garantia estendida US $ 8,3 milhões US $ 18.500 por contrato

Soluções de engenharia personalizadas

O VAREX fornece soluções de engenharia especializadas para fabricantes de equipamentos de imagem médica.

  • Receita de engenharia personalizada em 2023: US $ 16,4 milhões
  • Número de projetos de engenharia personalizados concluídos: 42
  • Valor médio do projeto: US $ 390.000

Suporte ao produto de pós -venda

O suporte ao produto de pós -venda gera receita adicional para a Varex Imaging Corporation.

Categoria de suporte Receita anual Taxa de crescimento
Peças de reposição US $ 28,6 milhões 4.2%
Suporte técnico US $ 12,9 milhões 3.7%

Varex Imaging Corporation (VREX) - Canvas Business Model: Value Propositions

For Computed Tomography (CT) and oncology applications, Varex Imaging Corporation delivers high-performance X-ray tubes. The demand for these components drove the Medical segment revenue to $152 million in the fourth quarter of fiscal year 2025, representing a 5% year-over-year increase. For the entirety of fiscal year 2025, the Medical segment generated $593 million in revenue.

The company provides advanced digital detectors, a core part of its offering, and is actively developing next-generation technology. Varex Imaging is advancing key growth initiatives, including the development of innovative technologies like photon counting for CT. Furthermore, the company successfully launched a new radiographic detector from its facility in India during fiscal year 2025.

Integrated cargo and vehicle inspection systems for security applications are a major value driver in the Industrial segment. This business saw sustained momentum, contributing to a 25% year-over-year increase in Industrial segment sales in the fourth quarter of fiscal year 2025, reaching $77 million. For the full fiscal year 2025, the Industrial segment revenue was $252 million. The company secured over $55 million in orders within its Industrial segment during fiscal year 2025, including receiving orders for high-energy non-intrusive cargo and vehicle inspection systems valued at approximately $25 million USD in the second quarter of fiscal year 2025.

Reliable replacement components and long-term product service support are embedded within the product lifecycle. The Medical segment components are used across a range of diagnostic radiography uses, including radiation therapy and CT. While specific service revenue figures aren't isolated, the business model supports these offerings through its established product lines.

System integration is supported by image processing software and connecting devices. Varex Imaging designs and manufactures components such as image-processing software and workstations. The product list for the third quarter of fiscal year 2025 specifically mentions IQ Software.

Here's a quick look at the segment performance that underpins these value propositions for the end of fiscal year 2025:

Segment Q4 FY2025 Revenue FY2025 Revenue
Medical (CT Tubes, Detectors) $152 million $593 million
Industrial (Inspection Systems) $77 million $252 million

The overall financial performance for the period reflects the strength in these areas:

  • Total Varex Imaging Corporation revenue for the fourth quarter of fiscal year 2025 was $229 million.
  • Total fiscal year 2025 revenue reached $845 million, a 4% growth year-over-year.
  • Non-GAAP EBITDA for fiscal year 2025 grew 37% to $122 million.
  • The company held cash, cash equivalents and marketable securities of $155 million at the end of fiscal year 2025.

Varex Imaging Corporation (VREX) - Canvas Business Model: Customer Relationships

You're looking at how Varex Imaging Corporation manages its connections with the entities buying its critical imaging components. It's a mix of deep partnership and transactional sales, which you can see reflected in their $845 million in total revenue for fiscal year 2025.

The relationship structure heavily favors the Medical segment, which generated $593 million in revenue for fiscal year 2025, suggesting deep, long-term collaborative relationships with major global OEMs are central to the business. For context, the Industrial segment brought in $252 million in the same period.

The reliance on established partners is clear when you look at the customer concentration from the prior year. The top 5 customers in fiscal year 2024 included Canon, United Imaging, GE, Rapiscan, and Siemens Healthineers.

This deep integration is supported by a massive installed base that drives recurring replacement and service demand. Here's a look at that installed base as of early 2025:

Asset Type Installed Base Count
X-ray tubes 160,000
Detectors 170,000
Connect & Control Components 600,000

The transactional sales model is likely most prominent in the replacement components business, which is a key driver for the Medical segment, alongside the direct sales for high-value industrial systems. The Industrial segment showed sustained momentum, with sales increasing 25% year-over-year in the fourth quarter of fiscal 2025, reaching $77 million for that quarter.

For those high-value industrial cargo systems, Varex Imaging Corporation secured over $55 million in orders and shipped more than 15 new cargo systems during fiscal year 2025. This segment also leverages its component expertise to provide differentiated value directly to end customers.

Customer-centric innovation is evidenced by the advancement of new technologies. The company highlighted the launch of a new radiographic detector from its facility in India and continued development of photon counting for CT in fiscal year 2025.

The overall revenue breakdown for fiscal year 2025 shows the scale of the different customer relationship types:

Segment FY2025 Revenue (Millions USD)
Medical $593
Industrial $252
Total Revenue $845

The company supports this global customer base with approximately 2,400 employees located across North America, Europe, and Asia, and protects its innovation through over 635 patents, with approximately 160 pending as of early 2025.

The relationship with distributors for transactional sales is supported by the need for replacement parts across the installed base, which is substantial. The company also has a significant intellectual property portfolio, with over 635 patents, which creates high barriers to entry and supports deep customer relationships due to custom-built hardware and software.

Finance: review Q1 2026 revenue guidance against Q4 2025 actuals by Tuesday.

Varex Imaging Corporation (VREX) - Canvas Business Model: Channels

You're looking at how Varex Imaging Corporation moves its high-tech components and systems to market, which is a mix of direct engagement for large Original Equipment Manufacturers (OEMs) and specialized sales for security applications. Honestly, the channel strategy is deeply tied to the segment performance we saw in fiscal year 2025.

The direct sales force is the backbone for reaching global OEM manufacturers, which is the primary channel for the Medical segment. This effort is supported by a global workforce of approximately 2,300 employees located across North America, Europe, and Asia, who are driving the sales and service of core components like X-ray tubes and detectors.

For the Industrial segment, which includes cargo inspection systems sold to government and security entities, the channel is more direct and tender-driven. This channel showed significant momentum in fiscal year 2025. The Industrial segment revenue reached $252 million for the full year, marking a $22.7 million increase compared to fiscal year 2024. Specifically within this direct sales channel for security, Varex Imaging Corporation secured over $55 million in new orders and shipped more than 15 new cargo systems during fiscal year 2025. The fourth quarter of 2025 was particularly strong here, with Industrial segment revenue hitting $77 million, a 25% increase year-over-year.

The company supports its installed base and aftermarket needs through a network of distributors and independent service organizations, which is key for replacement parts. This complements the direct sales model.

Varex Imaging Corporation maintains a physical global footprint to support these channels. While the exact number fluctuates, the company has established operations spanning multiple continents. You can see this global reach through their listed entities and offices in regions including:

  • North America (Headquarters in Salt Lake City, Utah)
  • Europe (Locations in Switzerland, Germany, and France)
  • Asia (Locations in China and India)
  • The Middle East (Saudi Arabia)
  • South America (Brazil)

This network supports both OEM integration and aftermarket service delivery across their customer base.

To support the complex equipment sold through these channels, Varex Imaging Corporation offers online and direct customer support for technical documentation. This is crucial for their OEM partners integrating components and for service providers maintaining installed systems. The company's total estimated backlog at October 3, 2025, stood at approximately $262 million, representing orders yet to be recognized as revenue, which flows through these established channels.

Here's a quick look at how the segments that rely on these channels performed in the final quarter and the full fiscal year 2025:

Metric Q4 FY2025 Amount FY2025 Amount
Total Revenue $229 million $845 million
Medical Segment Revenue $152 million $593 million
Industrial Segment Revenue $77 million $252 million
Industrial Segment YoY Growth 25% $22.7 million increase
Cargo Systems Orders Secured (FY25) N/A Over $55 million

Finance: draft 13-week cash view by Friday.

Varex Imaging Corporation (VREX) - Canvas Business Model: Customer Segments

You're looking at the core customer groups Varex Imaging Corporation serves based on their latest fiscal year reporting. This helps map where the $845 million in total revenue for fiscal year 2025 came from.

Medical OEMs

This group represents the largest portion of Varex Imaging Corporation's business. The Medical segment generated $593 million in revenue for the full fiscal year 2025. Global CT tube sales were a key driver in the fourth quarter of 2025, with Medical segment revenue reaching $152 million for that quarter. Major global manufacturers incorporating Varex Imaging Corporation's components include Canon, GE, and Siemens Healthineers, who were listed among the top 5 customers in fiscal year 2024.

The Medical segment saw an overall revenue increase of $10.9 million in fiscal year 2025 compared to fiscal year 2024. This growth was primarily fueled by increased sales in CT, oncology, and mammography modalities totaling $24.6 million.

Industrial OEMs and System Integrators

The Industrial segment delivered $252 million in revenue for the full fiscal year 2025, showing strength with a 25% year-over-year increase in the fourth quarter of 2025, where it brought in $77 million. Varex Imaging Corporation secured over $55 million in orders within this segment during fiscal year 2025. The segment's success in the fourth quarter was sustained by momentum in cargo systems.

Security and Border Control Agencies

This customer base is served through the Industrial segment, often via system integrators. Increased security inspection products sales of $13.3 million contributed to the Americas revenue growth in fiscal year 2025. Rapiscan was noted as a top 5 customer in fiscal year 2024, aligning with this application area. Varex Imaging Corporation shipped more than 15 new cargo systems during fiscal year 2025.

Independent Service Providers

While specific revenue is not broken out for service-only providers, the installed base drives replacement and service demand. The installed base as of fiscal year 2024 included 160,000 X-ray tubes and 170,000 detectors. The company also has 600,000 connect & control components in the field.

Veterinary and Dental Imaging System Manufacturers

These specific modalities are grouped within the Medical segment but showed a sales decrease in fiscal year 2025. Decreased sales in veterinary and dental modalities accounted for a reduction of $13.7 million in Medical segment sales compared to fiscal year 2024. Specifically, veterinary sales decreased by $4.7 million in the Americas region during fiscal year 2025.

Here's a quick math on the segment revenue contribution for the full fiscal year 2025:

Customer Group Proxy Varex Segment FY2025 Revenue (Millions USD) FY2025 Q4 Revenue (Millions USD)
Medical OEMs, Veterinary, Dental Medical $593 $152
Industrial OEMs, Security/Border Control Industrial $252 $77

Total revenue for fiscal year 2025 was $845 million. Total revenue for the fourth quarter of fiscal year 2025 was $229 million.

The geographic distribution of sales also impacts these segments, with total sales of medical X-ray tubes imported into China representing approximately 10% of total revenue in fiscal year 2025.

You can see the customer base is heavily weighted toward the Medical side, which is typical for Varex Imaging Corporation.

  • Medical Segment Percentage of FY2025 Revenue: ($593M / $845M) $\approx$ 70.18%
  • Industrial Segment Percentage of FY2025 Revenue: ($252M / $845M) $\approx$ 29.82%

Finance: draft 13-week cash view by Friday.

Varex Imaging Corporation (VREX) - Canvas Business Model: Cost Structure

You're analyzing the cost side of Varex Imaging Corporation's business, and it's clear that complex engineering translates directly into significant fixed and variable costs. The nature of high-precision X-ray component manufacturing means that the Cost of Goods Sold (COGS) is a major lever on profitability, so you need to watch that gross margin like a hawk.

Significant Cost of Goods Sold (COGS) due to complex manufacturing; GAAP gross margin was 34% in FY25. This figure is consistent across the full fiscal year results announced in November 2025, though it dipped to 33% in the third quarter of FY25, showing some margin pressure during that period.

Manufacturing and operational costs are spread across a wide footprint. Varex Imaging Corporation maintains production facilities in multiple countries to support global scale and leverage regional advantages. These sites include locations in the US, the Netherlands, Germany, China, India, the Philippines, and Finland. The prompt suggests 13 global production sites, reflecting a substantial physical infrastructure investment required to support this complex operation.

High R&D expenses are necessary to fund next-generation technologies like photon counting, which is a key growth initiative. For the first quarter of fiscal year 2025 (1QFY25), Research and Development expenses were $23.5 million. This investment is crucial for maintaining technological leadership against in-house OEM manufacturing operations.

Selling, General, and Administrative (SG&A) expenses support the global sales and service network. For the nine months ended July 4, 2025, SG&A expenses totaled $103.5 million. This covers the overhead for supporting OEM customers and the service centers globally.

Financing costs are also a factor, especially given recent debt management activities. Interest expense on debt was notable in FY25, particularly due to the convertible notes. For the nine months ended July 4, 2025, the reported Interest Expense was $(9.4) million. The company planned to repay the outstanding principal of these Convertible Notes, which bore interest at an annual rate of 4.00%, using $200.0 million in cash on June 1, 2025, which significantly impacted cash flow in the period.

Here's a quick look at some of the key cost and margin figures for context:

Metric FY25 Full Year Amount/Rate Period Specific Amount (if applicable)
GAAP Gross Margin 34% 33% (Q3 FY25)
SG&A Expenses Not explicitly stated for FY25 $103.5 million (Nine Months Ended July 4, 2025)
R&D Expense Not explicitly stated for FY25 $23.5 million (Q1 FY25)
Interest Expense Not explicitly stated for FY25 $(9.4) million (Nine Months Ended July 4, 2025)
Convertible Note Interest Rate 4.00% Settled with $200.0 million cash payment in June 2025

The cost structure is heavily weighted toward the direct costs of complex component creation, but the necessary ongoing investment in R&D to maintain product relevance is substantial, defintely impacting the operating margin, which was (3)% GAAP for the full year 2025.

Finance: draft 13-week cash view by Friday.

Varex Imaging Corporation (VREX) - Canvas Business Model: Revenue Streams

You're looking at the core money-makers for Varex Imaging Corporation as of late 2025. Honestly, the business model is straightforward: they sell the critical components that make X-ray machines work, split between the medical world and the industrial/security world.

For the full fiscal year 2025, Varex Imaging Corporation posted total revenues of $845 million. This total revenue was split across two primary operating segments. The Medical Segment Product Sales generated $593 million in FY25, which the company noted was driven by global CT tube sales. Also, the Industrial Segment Product Sales brought in $252 million for FY25, showing sustained momentum in cargo systems. So, the quick math shows that $593 million plus $252 million equals the total $845 million revenue for the year.

Here is a look at the segment revenue contribution for fiscal year 2025:

Revenue Stream Segment FY25 Revenue Amount
Medical Segment Product Sales $593 million
Industrial Segment Product Sales $252 million

The product sales are more granular than just the segment totals, covering specific components and markets. Sales of X-ray tubes are central to the business, supplying both OEMs and the replacement market across CT, general radiography, and mammography applications. For example, in the fourth quarter of 2025, Medical segment revenue was $152 million, up 5% year-over-year, driven by CT tube demand.

The Industrial segment's strength in Q4FY25, which hit $77 million (up 25% year-over-year), was tied to cargo systems. Looking at the product mix across regions in FY25, you see revenue derived from:

  • Sales of X-ray tubes, with regional increases in Americas of $4.7 million and APAC of $14.7 million.
  • Sales of digital detectors and image processing software, with EMEA showing a $4.3 million increase from digital detector sales and APAC showing a $1.8 million increase from digital detector sales.
  • Security inspection products, which saw an increase in Americas sales of $13.3 million.
  • CT, oncology, and mammography sales within the Medical segment increased by $24.6 million in FY25 compared to FY24.

Finally, Varex Imaging Corporation also generates revenue from service and maintenance from its installed base, which includes over 160,000 X-ray tubes and 170,000 X-ray detectors worldwide as of late 2025. Finance: draft 13-week cash view by Friday.


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.